Cargando…

MyoRing treatment of myopia

INTRODUCTION: Laser Vision Correction is not always possible for the treatment of myopia. The aim of this paper is to present results after MyoRing implantation in myopic eyes who in their majority were not eligible for LVC. Safety, effectivity and patient selection is discussed. The aim of the trea...

Descripción completa

Detalles Bibliográficos
Autor principal: Daxer, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484779/
https://www.ncbi.nlm.nih.gov/pubmed/27461520
http://dx.doi.org/10.1016/j.optom.2016.06.003
_version_ 1783245935718957056
author Daxer, Albert
author_facet Daxer, Albert
author_sort Daxer, Albert
collection PubMed
description INTRODUCTION: Laser Vision Correction is not always possible for the treatment of myopia. The aim of this paper is to present results after MyoRing implantation in myopic eyes who in their majority were not eligible for LVC. Safety, effectivity and patient selection is discussed. The aim of the treatment was to be spectacle independent in everyday-life. MATERIALS AND METHODS: 19 myopic eyes of 12 patients ranging from −2.25 to −16.5 dioptres (D) in sphere and from 0 to −4 D in cylinder were analyzed. RESULTS: After treatment, 84% of the eyes reached uncorrected distance visual acuity (UDVA) of 0.5 or better, 42% reached UDVA of 0.8 or better and 16% reached UDVA of 1.0 or better. Before treatment, no eye reached UDVA of 0.5 or better. Corrected distance visual acuity (CDVA) preoperatively and postoperatively did not differ. The treatment changed the average spherical equivalent from −10.27 D to −0.93 D. Efficacy index was 0.76 and safety index was 1.02. CONCLUSION: MyoRing implantation for myopia is safe and effective with highly satisfied patents in a particular subgroup of myopic patients. Patient selection is important.
format Online
Article
Text
id pubmed-5484779
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-54847792017-07-10 MyoRing treatment of myopia Daxer, Albert J Optom Original Article INTRODUCTION: Laser Vision Correction is not always possible for the treatment of myopia. The aim of this paper is to present results after MyoRing implantation in myopic eyes who in their majority were not eligible for LVC. Safety, effectivity and patient selection is discussed. The aim of the treatment was to be spectacle independent in everyday-life. MATERIALS AND METHODS: 19 myopic eyes of 12 patients ranging from −2.25 to −16.5 dioptres (D) in sphere and from 0 to −4 D in cylinder were analyzed. RESULTS: After treatment, 84% of the eyes reached uncorrected distance visual acuity (UDVA) of 0.5 or better, 42% reached UDVA of 0.8 or better and 16% reached UDVA of 1.0 or better. Before treatment, no eye reached UDVA of 0.5 or better. Corrected distance visual acuity (CDVA) preoperatively and postoperatively did not differ. The treatment changed the average spherical equivalent from −10.27 D to −0.93 D. Efficacy index was 0.76 and safety index was 1.02. CONCLUSION: MyoRing implantation for myopia is safe and effective with highly satisfied patents in a particular subgroup of myopic patients. Patient selection is important. Elsevier 2017 2016-07-25 /pmc/articles/PMC5484779/ /pubmed/27461520 http://dx.doi.org/10.1016/j.optom.2016.06.003 Text en © 2016 Spanish General Council of Optometry. Published by Elsevier Espa˜na, S.L.U. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Daxer, Albert
MyoRing treatment of myopia
title MyoRing treatment of myopia
title_full MyoRing treatment of myopia
title_fullStr MyoRing treatment of myopia
title_full_unstemmed MyoRing treatment of myopia
title_short MyoRing treatment of myopia
title_sort myoring treatment of myopia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484779/
https://www.ncbi.nlm.nih.gov/pubmed/27461520
http://dx.doi.org/10.1016/j.optom.2016.06.003
work_keys_str_mv AT daxeralbert myoringtreatmentofmyopia